rethinkPeptides Search
Menu
Study breakdown

KPV Peptide Reduces Crystal-Induced Inflammation as Effectively as Full Alpha-MSH

Animal StudyModerate evidence
The takeaway

The tripeptide KPV (alpha-MSH 11-13) reduced crystal-induced peritonitis as effectively as full-length alpha-MSH when administered systemically, confirming the C-terminal fragment retains the complete anti-inflammatory activity.

3 amino acids = full effect

KPV matched 13-amino-acid alpha-MSH for anti-inflammatory activity — nature's most compact anti-inflammatory signal

What the researchers found

KPV (alpha-MSH 11-13) reduced crystal-induced peritonitis as effectively as full-length alpha-MSH via systemic administration, with melanocortin receptor-independent anti-inflammatory activity at the inflammation site.

Why it matters

A 3-amino-acid peptide with full anti-inflammatory activity is incredibly practical for drug development — tiny, cheap to produce, and potentially orally bioavailable.

How the study worked

Animal study using crystal-induced peritonitis model. Systemic administration of alpha-MSH, KPV (11-13), core peptide HFRW (6-9), and fragments. Inflammatory cell infiltration and cytokine production measured.

What this study cannot tell us

Mouse peritonitis model. The melanocortin receptor-independent mechanism needs further characterization. Systemic dosing — local delivery effects not compared.

How to read the evidence

Moderate evidence from a controlled animal inflammation model with direct comparison to full-length peptide.

When this study was published

Published in 2003. KPV's anti-inflammatory properties have been further validated, with growing clinical interest for IBD and other inflammatory conditions.

The bigger picture

KPV demonstrates that nature's most essential anti-inflammatory signal can be captured in just three amino acids. This efficiency is remarkable and makes KPV one of the most practical peptide drug candidates.

Questions still open

  • Can oral KPV achieve anti-inflammatory concentrations?
  • What is KPV's non-melanocortin receptor anti-inflammatory mechanism?
  • Could KPV treat gout and other crystal-induced diseases?

Common questions

What is KPV?
Just three amino acids (Lys-Pro-Val) from the end of alpha-MSH. Despite being incredibly tiny, it has the full anti-inflammatory power of the complete 13-amino-acid peptide.
Could KPV treat gout?
This study models gout-like crystal inflammation, and KPV was highly effective. Its anti-inflammatory mechanism — which doesn't require melanocortin receptors at the inflammation site — makes it a promising candidate for crystal diseases like gout.

Read the original research

Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.

The Journal of pharmacology and experimental therapeutics, 306(2), 631-7

Citation

Getting, Stephen J; Schiöth, Helgi B; Perretti, Mauro. (2003). Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.. The Journal of pharmacology and experimental therapeutics, 306(2), 631-7.